Actuate Therapeutics, Inc.
ACTU- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001652935
No open-market purchases or sales by Actuate Therapeutics, Inc. insiders were filed in the last 90 days; 62 institutions reported holding it in 13F filings for Q2 2026, worth $20.6M in total; no superinvestor holds it.
Q1 2026 vs. Q4 2025
How the institutions holding Actuate Therapeutics, Inc. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Of which not filed for Q1 2026 | Q1 2026 | Change |
|---|---|---|---|---|
| Holders | 45 | 2 | 61 | +18 |
| Shares | 13.1M | 535.4K | 13.9M | +1.28M (+10.2%) |
| Value | $80.2M | $3.28M | $38.0M | −$39.0M (−50.7%) |
2 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (22)
Institutions that held Actuate Therapeutics, Inc. at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vanguard Capital Management LLC | 400,529 | $1.10M | 0.00% |
| Connective Capital Management, LLC | 113,266 | $310.3K | 0.26% |
| Palogic Value Management, L.P. | 100,000 | $274.0K | 0.12% |
| Vanguard Fiduciary Trust Co | 62,592 | $171.5K | 0.00% |
| Vanguard Portfolio Management LLC | 55,536 | $152.2K | 0.00% |
| AQR Capital Management LLC | 27,109 | $74.3K | 0.00% |
| XTX Topco Ltd | 15,118 | $41.4K | 0.00% |
| Goldman Sachs Group Inc | 12,408 | $34.0K | 0.00% |
| Vanguard Global Advisers, LLC | 5,102 | $14.0K | 0.00% |
| GAMMA Investing LLC | 286 | $784 | 0.00% |
| Nisa Investment Advisors, LLC | 87 | $238 | 0.00% |
| Essential Partners LLC | 48 | $132 | 0.00% |
| Allworth Financial LP | 40 | $110 | 0.00% |
| The PNC Financial Services Group, Inc. | 17 | $47 | 0.00% |
| Rothschild Investment LLC | 13 | $36 | 0.00% |
| SRS Capital Advisors, Inc. | 9 | $25 | 0.00% |
| Wealth Preservation Advisors, LLC | 7 | $19 | 0.00% |
| MAI Capital Management | 6 | $17 | 0.00% |
| Farther Finance Advisors, LLC | 7 | $17 | 0.00% |
| Root Financial Partners, LLC | 5 | $14 | 0.00% |
| IFP Advisors, Inc | 1 | $3 | 0.00% |
| SJS Investment Consulting Inc. | 1 | $3 | 0.00% |
Sold out (4)
Institutions that held Actuate Therapeutics, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Jane Street Group, LLC | 16,625 | $101.7K |
| Susquehanna International Group, LLP | 10,253 | $62.7K |
| California State Teachers Retirement System | 585 | $3.58K |
| Amalgamated Bank | 298 | $2.00K |
Not filed for Q1 2026 yet (2)
Institutions that held Actuate Therapeutics, Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Vanguard Group Inc | 529,111 | $3.24M |
| Global Retirement Partners, LLC | 6,250 | $38.3K |